Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Deferred Taxes (2016 - 2025)

Dexcom (DXCM) has disclosed Deferred Taxes for 16 consecutive years, with -$6.2 million as the latest value for Q4 2025.

  • Quarterly Deferred Taxes fell 110.32% to -$6.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $97.1 million through Dec 2025, up 162.43% year-over-year, with the annual reading at -$11.5 million for FY2025, 43.75% down from the prior year.
  • Deferred Taxes for Q4 2025 was -$6.2 million at Dexcom, down from $118.0 million in the prior quarter.
  • The five-year high for Deferred Taxes was $118.0 million in Q3 2025, with the low at -$52.3 million in Q4 2022.
  • Average Deferred Taxes over 5 years is $6.3 million, with a median of -$450000.0 recorded in 2021.
  • The sharpest move saw Deferred Taxes surged 50400.0% in 2022, then plummeted 9400.0% in 2023.
  • Over 5 years, Deferred Taxes stood at $15.6 million in 2021, then plummeted by 435.26% to -$52.3 million in 2022, then skyrocketed by 83.75% to -$8.5 million in 2023, then surged by 807.06% to $60.1 million in 2024, then plummeted by 110.32% to -$6.2 million in 2025.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$6.2 million, $118.0 million, and -$8.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.